NPI: 1538214713 · NORFOLK, VA 23502 · Pediatrics Physician · NPI assigned 01/25/2007
Authorized official ABSHIRE, KATHRYN controls 20+ related entities in our dataset. Read more
| Authorized Official | ABSHIRE, KATHRYN (SENIOR VP/CFO) |
| Parent Organization | CHILDRENS MEDICAL GROUP INC |
| NPI Enumeration Date | 01/25/2007 |
Other providers sharing the same authorized official: ABSHIRE, KATHRYN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 17,968 | $701K |
| 2019 | 39,653 | $1.46M |
| 2020 | 39,631 | $1.31M |
| 2021 | 48,538 | $1.36M |
| 2022 | 47,448 | $1.46M |
| 2023 | 50,715 | $1.56M |
| 2024 | 43,623 | $1.32M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 56,185 | 52,755 | $3.52M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 16,137 | 15,722 | $1.33M |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 11,815 | 11,171 | $1.07M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 13,062 | 11,178 | $1.02M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 9,891 | 9,687 | $795K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2,862 | 2,817 | $252K |
| 90686 | 18,604 | 18,084 | $227K | |
| 90670 | 5,572 | 5,324 | $112K | |
| 96127 | 17,995 | 15,390 | $94K | |
| 99199 | Unlisted special service, procedure or report | 10,114 | 5,161 | $62K |
| 87428 | 1,548 | 1,495 | $57K | |
| 96160 | 21,531 | 20,189 | $53K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3,314 | 3,229 | $49K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 5,252 | 3,957 | $48K |
| 92551 | 4,504 | 4,387 | $47K | |
| 90651 | 1,211 | 1,174 | $42K | |
| 90698 | 2,579 | 2,451 | $40K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1,113 | 1,045 | $40K |
| 96161 | 12,618 | 11,679 | $31K | |
| 90677 | 745 | 701 | $26K | |
| 90680 | 1,547 | 1,466 | $24K | |
| 90656 | 1,225 | 1,222 | $24K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1,562 | 753 | $23K |
| 99174 | 3,594 | 3,500 | $20K | |
| 90671 | 646 | 604 | $17K | |
| 80061 | Lipid panel | 1,170 | 1,131 | $16K |
| 90633 | 1,125 | 1,094 | $14K | |
| 85018 | 5,483 | 5,314 | $14K | |
| 90697 | 630 | 590 | $13K | |
| 1128F | 27,927 | 26,276 | $12K | |
| 99173 | 3,922 | 3,839 | $10K | |
| 90685 | 809 | 781 | $10K | |
| 83655 | 762 | 741 | $10K | |
| 90744 | 573 | 533 | $7K | |
| 90619 | 202 | 193 | $7K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 181 | 180 | $6K |
| 0071A | 118 | 117 | $5K | |
| 99188 | 199 | 194 | $4K | |
| 0072A | 104 | 99 | $4K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 220 | 200 | $4K |
| 36416 | 9,358 | 9,062 | $3K | |
| 99000 | 1,477 | 1,436 | $2K | |
| 0001A | 57 | 56 | $2K | |
| 90734 | 79 | 77 | $2K | |
| 90710 | 63 | 56 | $1K | |
| 0002A | 31 | 31 | $1K | |
| 1127F | 3,503 | 3,372 | $1K | |
| 90715 | 56 | 54 | $937.23 | |
| 81003 | 405 | 380 | $930.29 | |
| 91321 | 26 | 25 | $830.92 | |
| 90620 | 12 | 12 | $796.25 | |
| 90696 | 47 | 39 | $559.95 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 48 | 48 | $367.55 |
| 90716 | 27 | 27 | $311.85 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 31 | 30 | $298.63 |
| 90707 | 15 | 15 | $178.75 | |
| 99051 | 138 | 131 | $168.44 | |
| 90700 | 14 | 14 | $164.27 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 13 | 12 | $136.68 |
| 94760 | 125 | 119 | $92.75 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 26 | 25 | $34.45 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 62 | 57 | $8.40 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 14 | 14 | $1.80 |
| 91300 | 240 | 225 | $1.58 | |
| G9920 | Screening performed and negative | 28 | 28 | $0.00 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 2,756 | 2,592 | $0.00 |
| 91307 | 274 | 264 | $0.00 |